4//SEC Filing
Dolan Matthew Vincent 4
Accession 0001093557-23-000077
CIK 0001093557other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:46 PM ET
Size
11.2 KB
Accession
0001093557-23-000077
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Dolan Matthew Vincent
EVP, Strategy & Corporate Dev
Transactions
- Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−1,370$152,617→ 46,935 total - Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−1,650$183,808→ 45,285 total - Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−787$87,671→ 42,101 total - Sale
Common Stock
2023-03-13$106.27/sh−6,229$661,956→ 35,872 total - Disposition to Issuer
Common Stock
2023-03-10$111.40/sh−2,397$267,023→ 42,888 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 33,569 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
- [F3]On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001914994
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:46 PM ET
- Size
- 11.2 KB